Ledger.Open graph →
SEC Form D · filed October 28, 2022

Pheast Therapeutics, Inc

Offering
$75.3M
Sold
$25.2M
Exemption
Rule 506(b)
Industry
Other Technology
Location
PALO ALTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Steven Gillis · Ann Arbor, MIDirectorJacob Vogelstein · Baltimore, MDDirectorAmira Barkal · Palo Alto, CAExec · DirectorIrving Weissman · Palo Alto, CADirectorJacob Vogelstein · Baltimore, MDDirectorSteven Gillis · Chicago, ILDirectorAmira Barkal · Palo Alto, CAExec · DirectorIrving Weissman · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗